Adverse reactions of tuberculosis treatment in pacients with and without associated digestive disorders

M. A. Man, C. M. Pop, C. D. Zamora, M. A. Goron, R. Gherasim (Cluj-Napoca, Romania)

Source: Annual Congress 2003 - Management of tuberculosis
Session: Management of tuberculosis
Session type: Thematic Poster Session
Number: 3254
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. A. Man, C. M. Pop, C. D. Zamora, M. A. Goron, R. Gherasim (Cluj-Napoca, Romania). Adverse reactions of tuberculosis treatment in pacients with and without associated digestive disorders. Eur Respir J 2003; 22: Suppl. 45, 3254

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Adverse reactions to the tuberculosis treatment
Source: Eur Respir J 2001; 18: Suppl. 33, 340s
Year: 2001

Adverse effects of treatment in HIV-associated tuberculosis patients in Iran
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011


Risk of serious adverse reactions during the treatment of new tuberculosis patients
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012

Adverse events during treatment for latent tuberculosis infection
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011

Adverse reactions in the treatment of patients with non-tuberculous pulmonary mycobacteriosis.
Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Year: 2021


Adverse events in the treatment of multidrug-resistant tuberculosis
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011

Management of adverse drug events in TB therapy
Source: Eur Respir Mon 2012; 58: 167-193
Year: 2012


Adverse effects of chemotherapy in patients with multidrug-resistant tuberculosis with alcohol abuse and without one
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018

Adverse effects of moxifloxacin during tuberculosis treatment
Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment
Year: 2012

Possible neuropsychic adverse reactions with montelukast in childhood asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 263s
Year: 2001

Adverse events during treatment of nontuberculous mycobacterial lung disease: do they really matter?
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018

Adverse anti-tuberculosis drug events and their management
Source: Eur Respir Monogr 2018; 82: 205-227
Year: 2018


Risk of adverse effects of antitubercular drugs in patients with pulmonary tuberculosis and low active viral hepatitis C and other digestive tract diseases
Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups
Year: 2008


PCR tests in atypical infections of respiratory tract in children and the impact of these infections on the childhood asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


Concomitant intestinal parasitic infections in patients with respiratory disease
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013


Adverse events in the treatment of patients with pulmonary tuberculosis combined with diabetes mellitus and without it.
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021


Impact of adverse drug reactions on treatment interruption in TB patients with and without HIV coinfection
Source: ISSN=ISSN 1810-6838, ISBN=, page=190
Year: 2006

Severe adverse reactions in asthmatic children treated with specific immunotherapy(s.I.T.)
Source: Eur Respir J 2003; 22: Suppl. 45, 318s
Year: 2003

Adverse drug reactions in a pulmonary teaching hospital: Incidence, pattern, seriousness, and preventability
Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases
Year: 2011

Unusual mycoplasmas detected in subjects with respiratory disorders associated or not to severe clinical underlying conditions
Source: Eur Respir J 2001; 18: Suppl. 33, 305s
Year: 2001